Skip to main content
OpenTrials

Clinical trial condition

Renal Cancer

Explore clinical trials studying Renal Cancer. Study availability and eligibility vary by location and protocol.

112 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Renal Cancer trial results

Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

NCT01109394

Conditions
Endocrine Tumors, Eye Diseases, Eye Diseases, Hereditary, +27 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Hospital of Orange County (CHOC Children's) Orange, Florida, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Tisch Cancer Institute, Mount Sinai Medical Center New York, United States
View Trial Details
Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 128 locations
View Trial Details
Recruiting

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT06239194

Conditions
Biliary Tract Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +74 more
Locations
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Sylvester Comprehensive Cancer Center - University of Miami Health System Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View Trial Details

Related conditions